Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

J&J agrees to pay $230M to settle New York opioid claim

The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis

Via AP news wire
Saturday 26 June 2021 16:04 BST
Opioid Lawsuit Settlement
Opioid Lawsuit Settlement (Copyright 2021The Associated Press. All rights reserved)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis.

The deal announced on Saturday requires Johnson & Johnson to make a series of payments over nine years that will cover the total. The drugmaker also agreed to end the manufacturing and distribution of opioids across New York and the rest of the nation, Attorney General Letitia James said in statement.

The company “helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country,” James said.

Johnson & Johnson said in a statement on Saturday that the settlement “is not an admission of liability or wrongdoing by the company."

It added that its actions “relating to the marketing and promotion of important prescription pain medications were appropriate and responsible.”

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in